| For: | Zhang YQ, Tang XQ, Sun L, Dong L, Qin Y, Liu HQ, Xia H, Cao JG. Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor γ. World J Gastroenterol 2007; 13(10): 1534-1540 [PMID: 17461445 DOI: 10.3748/wjg.v13.i10.1534] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i10/1534.htm |
| Number | Citing Articles |
| 1 |
Hong-Yuan Wang, Ying Zhang, Yue Zhou, Yu-Yin Lu, Wen-Fang Wang, Ming Xin, Xiu-Li Guo. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway. Biomedicine & Pharmacotherapy 2016; 83 doi: 10.1016/j.biopha.2016.06.047
|
| 2 |
Liudmila L Kodach, Rutger J Jacobs, Philip W Voorneveld, Manon E Wildenberg, Henricus W Verspaget, Tom van Wezel, Hans Morreau, Daniel W Hommes, Maikel P Peppelenbosch, Gijs R van den Brink, James C H Hardwick. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness’ via the bone morphogenetic protein pathway. Gut 2011; 60(11) doi: 10.1136/gut.2011.237495
|
| 3 |
YASUHIRO YAMAMOTO, HIROMI KOMA, HIROKI HIRAMATSU, MISA ABE, KAZUNORI MURAKAMI, ASAKO OHYA, TATSUROU YAGAMI. Treatment of etoposide combined with 15-deoxy-Δ12,14-prostaglandin J2 exerted synergistic antitumor effects against renal cell carcinoma via peroxisome proliferator-activated receptor-γ-independent pathways. Molecular and Clinical Oncology 2014; 2(2) doi: 10.3892/mco.2013.234
|
| 4 |
Cristina P. R. Xavier, Cristovao F. Lima, Mikkel Rohde, Cristina Pereira-Wilson. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Cancer Chemotherapy and Pharmacology 2011; 68(6) doi: 10.1007/s00280-011-1641-9
|
| 5 |
Xiang-Wen Tan, Hong Xia, Jin-Hua Xu, Jian-Guo Cao. Induction of apoptosis in human liver carcinoma HepG2 cell line by 5-allyl-7-gen-difluoromethylenechrysin. World Journal of Gastroenterology 2009; 15(18): 2234-2239 doi: 10.3748/wjg.15.2234
|
| 6 |
Sandrine Théoleyre, Stéphanie Mottier, Damien Masson, Marc G. Denis. HtrA3 is regulated by 15-deoxy-Δ12,14-prostaglandin J2 independently of PPARγ in clear cell renal cell carcinomas. Biochemical and Biophysical Research Communications 2010; 394(3) doi: 10.1016/j.bbrc.2009.11.163
|
| 7 |
Stephanie K. Bunt, Ashley M. Mohr, Jennifer M. Bailey, Paul M. Grandgenett, Michael A. Hollingsworth. Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer. Cancer Immunology, Immunotherapy 2013; 62(2) doi: 10.1007/s00262-012-1324-3
|
| 8 |
Tamotsu Tsukahara, Shuwa Hanazawa, Tetsuyuki Kobayashi, Yoshiki Iwamoto, Kimiko Murakami-Murofushi. Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor γ. Prostaglandins & Other Lipid Mediators 2010; 93(3-4) doi: 10.1016/j.prostaglandins.2010.09.002
|
| 9 |
Piotr Mrowka, Eliza Glodkowska-Mrowka. PPARγ Agonists in Combination Cancer Therapies. Current Cancer Drug Targets 2020; 20(3) doi: 10.2174/1568009619666191209102015
|
| 10 |
Yu Yang, Kan Wang. Pharmacological mechanisms and clinical impacts of antidiabetic drugs on colorectal cancer risk: a systematic review. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1849647
|
| 11 |
Monica Susan, Ioana Macasoi, Iulia Pinzaru, Cristina Dehelean, Iosif Ilia, Razvan Susan, Ioana Ionita. In Vitro Assessment of the Synergistic Effect of Aspirin and 5-Fluorouracil in Colorectal Adenocarcinoma Cells. Current Oncology 2023; 30(7) doi: 10.3390/curroncol30070460
|
| 12 |
Jarmila Lauková, Alois Kozubík, Jiřina Hofmanová, Jana Nekvindová, Petr Sova, Mary Pat Moyer, Jiří Ehrmann, Alena Hyršlová Vaculová, Yoshiaki Tsuji. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. PLOS ONE 2015; 10(10) doi: 10.1371/journal.pone.0141020
|
| 13 |
Meng-Fei Lau, Kek-Heng Chua, Vikineswary Sabaratnam, Umah Rani Kuppusamy. Rosiglitazone enhances the apoptotic effect of 5-fluorouracil in colorectal cancer cells with high-glucose-induced glutathione. Science Progress 2020; 103(1) doi: 10.1177/0036850419886448
|
| 14 |
Zhao-Hui Xie, Mei-Fang Quan, Fei Liu, Jian-Guo Cao, Jian-Song Zhang. 5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-322
|
| 15 |
LI-HUA LIU, YING-JUN ZHOU, LAN DING, SHUN-ZHI ZHANG, JI SUN, JIAN-GUO CAO. Induction of apoptosis by VB1 in breast cancer cells: The role of reactive oxygen species and Bcl-2 family proteins. International Journal of Molecular Medicine 2014; 33(2) doi: 10.3892/ijmm.2013.1567
|
| 16 |
Leah Schöckel, Christine Woischke, Sai Agash Surendran, Marlies Michl, Tobias Schiergens, Andreas Hölscher, Florian Glass, Peter Kreissl, Frederick Klauschen, Michael Günther, Steffen Ormanns, Jens Neumann. PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-11985-5
|
| 17 |
Sherif Ashraf Fahmy, Nada K. Sedky, Hatem A. F. M. Hassan, Nour M. Abdel-Kader, Noha Khalil Mahdy, Muhammad Umair Amin, Eduard Preis, Udo Bakowsky. Synergistic Enhancement of Carboplatin Efficacy through pH-Sensitive Nanoparticles Formulated Using Naturally Derived Boswellia Extract for Colorectal Cancer Therapy. Pharmaceutics 2024; 16(10) doi: 10.3390/pharmaceutics16101282
|
| 18 |
Reza Meshkani, Asie Sadeghi, Gholamreza Taheripak, Maryam Zarghooni, Siavash Gerayesh‐Nejad, Salar Bakhtiyari. Rosiglitazone, a PPARγ agonist, ameliorates palmitate‐induced insulin resistance and apoptosis in skeletal muscle cells. Cell Biochemistry and Function 2014; 32(8) doi: 10.1002/cbf.3072
|
| 19 |
Yun Dai, Liang Qiao, Kwok Wah Chan, Bing Zou, Juan Ma, Hui Y. Lan, Qing Gu, Zesong Li, Yan Wang, Benny L.W. Wong, Benjamin C.Y. Wong. Loss of XIAP sensitizes rosiglitazone‐induced growth inhibition of colon cancer in vivo. International Journal of Cancer 2008; 122(12) doi: 10.1002/ijc.23443
|
| 20 |
Liang-qi Cao, Xiao-li Wang, Qian Wang, Ping Xue, Xing-yuan Jiao, He-ping Peng, Hai-wu Lu, Qiang Zheng, Xi-lin Chen, Xiao-hui Huang, Xin-hui Fu, Jing-song Chen. Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARγ signaling pathway. Acta Pharmacologica Sinica 2009; 30(9) doi: 10.1038/aps.2009.119
|
| 21 |
Yasuhiro Yamamoto, Megumi Fujita, Hiromi Koma, Motohiro Yamamori, Tsutomu Nakamura, Noboru Okamura, Tatsurou Yagami. 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways. Biochemical and Biophysical Research Communications 2011; 410(3) doi: 10.1016/j.bbrc.2011.06.026
|
| 22 |
Annika Bundscherer, Christian Hafner. Cancer Microenvironment and Therapeutic Implications. 2009; doi: 10.1007/978-1-4020-9576-4_12
|
| 23 |
Teodora Costea, Oana Cezara Vlad, Luminita-Claudia Miclea, Constanta Ganea, János Szöllősi, Maria-Magdalena Mocanu. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer. International Journal of Molecular Sciences 2020; 21(2) doi: 10.3390/ijms21020401
|
| 24 |
Julie Rageul, Stéphanie Mottier, Anne Jarry, Yatrik Shah, Sandrine Théoleyre, Damien Masson, Frank J. Gonzalez, Christian L. Laboisse, Marc G. Denis. KLF4‐dependent, PPARγ‐induced expression of GPA33 in colon cancer cell lines. International Journal of Cancer 2009; 125(12) doi: 10.1002/ijc.24683
|
| 25 |
Hong-Liang Liang, Qin Ouyang. A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis. World Journal of Gastroenterology 2008; 14(1): 114-119 doi: 10.3748/wjg.14.114
|
| 26 |
Shu-Jun Chiu, Ching-Hui Hsaio, Ho-Hsing Tseng, Yu-Han Su, Wen-Ling Shih, Jeng-Woei Lee, Jennifer Qiu-Yu Chuah. Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells. Biochemical and Biophysical Research Communications 2010; 394(3) doi: 10.1016/j.bbrc.2010.03.068
|
| 27 |
Graham Skelhorne-Gross, Christopher J. B. Nicol. The Key to Unlocking the Chemotherapeutic Potential of PPARγLigands: Having the Right Combination. PPAR Research 2012; 2012 doi: 10.1155/2012/946943
|
| 28 |
Eleonore Fröhlich, Richard Wahl. Chemotherapy and Chemoprevention by Thiazolidinediones. BioMed Research International 2015; 2015 doi: 10.1155/2015/845340
|
| 29 |
Geoffrey Girnun. PPARG: A New Independent Marker for Colorectal Cancer Survival. Gastroenterology 2009; 136(4) doi: 10.1053/j.gastro.2009.02.022
|
| 30 |
. 2010; doi: 10.70675/659c82ebzed88z45f4zbdb9z0440a121a800
|
| 31 |
Yasuhiro Yamamoto, Hiromi Koma, Tatsurou Yagami. 15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> Inhibits Cell Migration on Renal Cell Carcinoma <i>via</i> Down-Regulation of Focal Adhesion Kinase Signaling. Biological and Pharmaceutical Bulletin 2020; 43(1) doi: 10.1248/bpb.b19-00748
|